Advent Life Sciences is a transatlantic venture investor focused on building innovative life sciences businesses in the UK, Europe, and the USA. They invest in early and mid-stage companies, from seed to beyond, with a focus on new drug discovery, med-tech, enabling technologies, diagnostics, and vaccines, aiming to bring breakthrough science to approved medicines or medical products.